Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION) (NCT07684235)

🧪 Interventions in This Study

• Maridebart cafraglutide (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (83 Sites)

Showing the first 25 of 83 sites.

• Pinnacle Research Group LLC — Anniston, Alabama
• Alliance For Multispecialty Research - Daphne — Daphne, Alabama
• Alliance for Multispecialty Research Mobile — Mobile, Alabama
• Ark Clinical Research- Tustin — Fountain Valley, California
• Long Beach Clinical Trials Services Inc — Long Beach, California
• Ark Clinical Research- Long Beach — Long Beach, California
• Catalina Research Institute — Montclair, California
• Artemis Institute for Clinical Research — Riverside, California
• Apex Clinical Research — San Diego, California
• Artemis Institute for Clinical Research — San Diego, California
• Southern California Clinical Research — Santa Ana, California
• Diablo Clinical Research — Walnut Creek, California
• Chase Medical Research LLC — Waterbury, Connecticut
• Jacksonville Center for Clinical Research — Jacksonville, Florida
• Clinical Neuroscience Solutions - Jacksonville — Jacksonville, Florida
• South Florida Wellness and Clinical Research Institute — Margate, Florida
• Optimus U Corporation — Miami, Florida
• Research Institute of South Florida — Miami, Florida
• Indago Research and Health Center — Miami Lakes, Florida
• Renstar Medical Research — Ocala, Florida
• Clinical Neuroscience Solutions - Orlando — Orlando, Florida
• Combined Research Orlando Phase I IV — Orlando, Florida
• Florida Institute for Clinical Research — Orlando, Florida
• Encore Medical Research of Weston LLC — Weston, Florida
• Center for Advanced Research and Education — Gainesville, Georgia

📞 Contact the Study Coordinator

Phone: (866) 572-6436

Email: medinfo@amgen.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Obesity

• Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools — Tampa, Florida
• SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity — Tucson, Arizona
• Piloting a Patient Navigator Program for Weight Loss — Philadelphia, Pennsylvania
• Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) — Mesa, Arizona
• Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects — Orlando, Florida
• Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans — Pittsburgh, Pennsylvania

Explore by condition: All Obesity clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.